Featured Event Transfiere 2023 Málaga España Del 15/02/2023 to 17/02/2023 Healthcare Agrifood Industrial biotechnology International AseBio will play a leading role in Transfiere 2023 with talks and a stand next month in Malaga to showcase the work of...
Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
Featured Event Biotech Communications 101 Seminar - Consilium & AseBio Investor Day On-line Del 26/04/2022 15:00 to 26/04/2022 16:00 Healthcare Communication In the framework of the AseBio Investor Day 2022 that we are holding next Thursday 28th April, our partners have the...
Featured Event The Annual 2022 Two-Day IVD Conference Madrid España Del 24/03/2022 to 25/03/2022 Healthcare
ORYZON receives European Medicines Agency approval to initiate the HOPE-2 Phase II study ... 29/09/2026 Healthcare Rare diseases Innovative drugs PMS is a severely disabling genetic disorder related to autism. Partners - Oryzon Genomics
Investigar el cáncer con los pacientes: de destinatarios a parte activa de la investigació... 23/09/2026 Salud Acceso a la innovación Medicamentos innovadores Vanesa Abón Escalona, responsable del Programa Patient Advocacy AECC, explica cómo incorporar la experiencia de las... AseBio - Fundación Científica de la Asociación Española Contra el Cáncer
Seven organisations present a technical report supporting the need to review the implement... 21/09/2026 Healthcare Industrial biotechnology Bioeconomy Circular economy The report is presented at a time of growing European debate over the implementation of the Directive, following the... AseBio
Seven organisations present a technical report supporting the need to review the implement... 21/09/2026 The report is presented at a time of growing European debate over the implementation of the Directive, following the... AseBio
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 Healthcare Drug discovery Personalized medicine In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... Partners - ADmit Therapeutics
Biomarkers and artificial intelligence open new avenues for anticipating Alzheimer’s progr... 21/09/2026 ADmit Therapeutics In Spain, nearly one million people were living with dementia in 2025, according to estimates from Alzheimer Europe... AseBio - ADmit Therapeutics
